Concepedia

Werner Hoellriegl

WH

8

Publications

344

Citations

8

H-Index

2010

Active since

Affiliations

Takeda (Austria)(Current)

Baxter (Austria)

Mundipharma (United Kingdom)

Baxalta (United States)

Werner Hoellriegl is an author at Takeda (Austria) specializing in medicine, hematology, and oxidative stress.

Top concepts

Publications per year

2010–2022

8

Publications

8

A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13

Alexandra Schiviz, Kuno Wuersch, Christina Piskernik et al. · Blood · 2012 · 122 citations

Towards a standardization of the murine tail bleeding model

Teshell K. Greene, Alexandra Schiviz, Werner Hoellriegl et al. · Journal of Thrombosis and Haemostasis · 2010 · 89 citations

, , +7

Porcine recombinant factor <scp>VIII</scp> (Obizur; <scp>OBI</scp>‐1; <scp>BAX</scp>801): product characteristics and preclinical profile

David Lillicrap, Alexandra Schiviz, Christopher Apostol et al. · Haemophilia · 2015 · 32 citations

Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive <i>In Vitro</i> Assays

Anita Kruzik, Herwig Koppensteiner, Damir Fetahagic et al. · Human Gene Therapy Methods · 2019 · 27 citations · Full text

Evidence of protective effects of recombinant ADAMTS13 in a humanized model of sickle cell disease

Paolo Rossato, Enrica Federti, Alessandro Mattè et al. · Haematologica · 2022 · 21 citations · Full text

, , +18

Rows per page

1–5 of 8